-
-
-
-
-
-
-
-
7 . Periodical
The Prognostic Impact of HMGCLL1Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2ndGeneration Tyrosine Kinase Inhibitor (TKI) Upfront Therapy
- 저자
- by Perusini, Maria Agustina; Kim, Taehyung Simon; Žácková, Daniela; Pagnano, Katia B; Mayer, Jiří, et al.
- 소스
- Blood; November 2022, Vol. 140 Issue: 1, Number 1 Supplement 1 p6774-6775, 2p
-